BioSpace News Archive

Policy

Novartis, Current and Former Units Agree to Pay More than $346 Million to Settle U.S. Bribery Charges

Novartis, Novartis Hellas and Alcon Inc. have agreed to pay a total of more than $346 million to settle bribery charges under the Foreign Corrupt Practices Act (FCPA), which is a U.S. anti-bribery law.

June 25, 2020
·
2 min read
·
Ellen Bombela
Policy

U.S. Government Alleges Regeneron Used Kickbacks to Boost Eylea Sales

Regeneron Pharmaceuticals said it will vigorously defend federal charges that it was involved in a kickback scheme to bolster sales of its blockbuster macular degeneration drug, Eylea.

June 25, 2020
·
3 min read
·
Alex Keown
Career Advice

Some Not So Common Interview Questions You Should Always Ask at the End of an Interview

Most job applicants don’t know about questions that they should ask at the end of an interview. Here are some not-so-common interview questions that you must remember to ask.

June 25, 2020
·
2 min read
·
Laura Brothers
Drug Development

Biopharma Update on the Novel Coronavirus: June 26

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 26, 2020.

June 25, 2020
·
3 min read
·
BioSpace Editorial Staff
Business

Sanofi Considering Additional Restructuring and Up to 1,000 Job Cuts

According to a brief report by Reuters, the drug company plans to hold meetings with staff representatives tomorrow and Monday of next week to describe a restructuring plan, according to four sources familiar with the matter.

June 25, 2020
·
5 min read
·
Mark Terry
Business

Regenerative Medicine Needs a New, Digital Supply Chain

The supply chain that exists for traditional pharmaceuticals is woefully insufficient for regenerative medicine, according to Robert Lechich, principal manufacturing and supply chain consultant for Global OT/IT – Quality Services.

June 25, 2020
·
5 min read
·
Gail Dutton
Deals

NantKwest Announces Pricing of Public Offering of Common Stock - June 25, 2020

NantKwest, Inc., a clinical-stage, natural killer cell-based therapeutics company, announced the pricing of an underwritten public offering of an aggregate of 7,410,000 shares of its common stock.

June 25, 2020
·
3 min read
Deals

Enterome Completes €46.3 Million ($52.6 Million) Financing to Progress the Clinical Development of Its Therapeutic Pipeline

Lead ‘OncoMimics’ candidate EO2401 planned to start first clinical trials for Glioblastoma and Adrenal Tumors during mid-2020

June 25, 2020
·
5 min read
Canadian company AccessNow wins Novartis Innovation Prize for Assistive Tech

Initiated in late 2019, the Novartis Innovation Prize: Assistive Tech for Multiple Sclerosis (MS) identified and encouraged technology ideas from all over the world with the aim to improve mobility, accessibility and daily life for people living with MS

June 25, 2020
·
5 min read
Stevanato Group Signs an Agreement With the Coalition for Epidemic Preparedness Innovations (CEPI) to Provide Pharma Glass Vials for 2 Billion Doses of COVID-19 Vaccines Under Development

With this supply, Stevanato Group is playing a key role in the global challenge of scaling up the industrialization of glass vials, a critical component for the delivery of the vaccine

June 25, 2020
·
5 min read